Published in Triangle on January 01, 1975
Ergotamine abuse and extra-hepatic portal hypertension. Postgrad Med J (1985) 0.75
beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. Br J Clin Pharmacol (1976) 2.17
A new technique for recording compliance of human hand veins. Br J Clin Pharmacol (1981) 1.80
Blood levels of practolol following intravenous administration. Br J Pharmacol (1970) 1.61
Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol. Br J Pharmacol (1973) 1.35
Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man. Int J Clin Pharmacol Biopharm (1977) 1.19
Venoconstrictor effect of dihydroergotamine in superficial hand veins. Eur J Clin Pharmacol (1974) 1.15
The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia. Br J Clin Pharmacol (1982) 1.15
[Peripheral circulatory effects of ergotamine, dihyroergotamine and 1-methylergotamine on the innevated, perfused hindlimb of the o]. Helv Physiol Pharmacol Acta (1967) 1.11
Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. Br J Clin Pharmacol (1982) 1.08
Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity. Br J Clin Pharmacol (1985) 1.08
The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram. Postgrad Med J (1970) 1.03
Duration of action and plasma levels of beta-adrenoceptor blocking drugs. Arch Int Pharmacodyn Ther (1980) 0.95
Prolonged action of pindolol. Br Med J (1973) 0.94
Use of a linear variable differential transformer to measure compliance of human hand veins in situ [proceedings]. Br J Clin Pharmacol (1979) 0.91
Intravenous diazepam in minor oral surgery. Further studies. Br Dent J (1970) 0.91
Clinical pharmacology of pindolol. Am Heart J (1982) 0.91
The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise. Br J Pharmacol (1970) 0.86
Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man. Eur J Clin Pharmacol (1984) 0.84
Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol. Br J Clin Pharmacol (1986) 0.83
Cardiac effects of adrenaline and felypressin as vasoconstrictors in local anaesthesia for oral surgery under diazepam sedation. Br J Anaesth (1970) 0.83
Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed. Br J Pharmacol (1969) 0.82
A new technique for recording compliance of human hand veins. 1981. Br J Clin Pharmacol (2004) 0.82
Investigations with beta-adrenoceptor blocking drugs in healthy volunteers. Acta Med Scand Suppl (1977) 0.82
Methods for studying drug effects on superficial human veins. Methods Find Exp Clin Pharmacol (1985) 0.81
Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjects. Eur J Clin Pharmacol (1991) 0.81
Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers. Eur J Clin Pharmacol (1978) 0.81
[Clinicopharmacological studies with pindolol following intravenous and oral administration]. Adv Clin Pharmacol (1976) 0.80
A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet. Eur J Clin Pharmacol (1981) 0.79
Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration. Eur J Clin Pharmacol (1986) 0.78
Influence of ergot compounds on compliance of superficial hand veins in man. Postgrad Med J (1976) 0.78
Activity and duration of action of pindolol and alprenolol compared in healthy volunteers. Eur J Clin Pharmacol (1978) 0.77
Experiments with pindolol (Visken) in healthy volunteers. Med J Aust (1977) 0.76
Direct effects of vasoactive substances on superficial human veins in vivo. Int Angiol (1986) 0.76
Contrasts between pindolol and propranolol concentration-response relationships. Br J Clin Pharmacol (1985) 0.75
Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man. Eur J Clin Pharmacol (1983) 0.75
Vasovagal faint in the supine position. Br Med J (1970) 0.75
The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris. Br J Pharmacol (1969) 0.75
Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors. Adv Neurol (1982) 0.75
[Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ]. Cardiology (1976) 0.75
Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol. J Cardiovasc Pharmacol (1983) 0.75
Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets. Eur J Clin Pharmacol (1982) 0.75
Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol. J Cardiovasc Pharmacol (1986) 0.75